CN(C(=O)COC(=O)c1c2c(nc3ccccc13)CCCC2)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?